OPRX Insider Trading
Insider Ownership Percentage: 6.10%
Insider Buying (Last 12 Months): $2,542,900.80
Insider Selling (Last 12 Months): $0.00
OptimizeRx Share Price & Price History
Current Price: $8.74
Price Change: ▲ Price Increase of +0.08 (0.92%)
As of 04/28/2025 05:00 PM ET
OptimizeRx Insider Trading History
OptimizeRx Institutional Trading History
Data available starting January 2016
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Read More on OptimizeRx
Volume
136,124 shs
Average Volume
265,631 shs
Market Capitalization
$161.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.18
Who are the company insiders with the largest holdings of OptimizeRx?
Who are the major institutional investors of OptimizeRx?
Which institutional investors are buying OptimizeRx stock?
Within the last quarter, OPRX stock was purchased by institutional investors including:
- Janney Montgomery Scott LLC
- Calamos Advisors LLC
- GAMMA Investing LLC
- Rhumbline Advisers
Within the previous year, these company insiders have bought OptimizeRx stock:
- William J Febbo (CEO)
- James Paul Lang (Director)
Learn More investors buying OptimizeRx stock.